Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 NCT01407757 Leukemia
DNA analysis
gene expression...
laboratory biom...
pharmacogenomic...
- 29 Years Children's Oncology Group View Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia NCT00089050 Leukemia
cyclosporine
gemtuzumab ozog...
60 Years - Fred Hutchinson Cancer Center View Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia NCT01627041 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Alkylating Agen...
Secondary Acute...
Cytarabine
Daunorubicin Hy...
Decitabine
Laboratory Biom...
Pharmacological...
18 Years - 65 Years National Cancer Institute (NCI) View Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia NCT00101231 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Recurrent Adult...
Recurrent Adult...
Relapsing Chron...
alvocidib
1 Year - National Cancer Institute (NCI) View Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia NCT00093483 Leukemia
filgrastim
arsenic trioxid...
cytarabine
idarubicin
18 Years - 59 Years Roswell Park Cancer Institute View Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia NCT01159301 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Recurrent Adult...
Unspecified Adu...
entinostat
sorafenib tosyl...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia NCT00003758 Leukemia
cytarabine
idarubicin
allogeneic bone...
autologous bone...
peripheral bloo...
15 Years - 60 Years National Cancer Institute (NCI) View Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia NCT00217646 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult Erythrole...
Adult Pure Eryt...
Alkylating Agen...
Blastic Phase
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Secondary Myelo...
Sorafenib Tosyl...
18 Years - National Cancer Institute (NCI) View Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy NCT01235572 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Previously Trea...
Recurrent Adult...
standard follow...
medical chart r...
quality-of-life...
18 Years - 75 Years Fred Hutchinson Cancer Center View Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R NCT00534469 Leukemia
aldesleukin
filgrastim
busulfan
cytarabine
etoposide
idarubicin
autologous hema...
bone marrow tra...
peripheral bloo...
total-body irra...
16 Years - 60 Years City of Hope Medical Center View Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00027872 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Cellular Diagno...
Untreated Adult...
tipifarnib
laboratory biom...
65 Years - National Cancer Institute (NCI) View VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia NCT00354276 Leukemia
cytarabine
laromustine
60 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes NCT00454480 Leukemia
Myelodysplastic...
alemtuzumab
arsenic trioxid...
azacitidine
busulfan
clofarabine
cytarabine
daunorubicin hy...
fludarabine pho...
gemtuzumab ozog...
melphalan
tipifarnib
DNA methylation...
cytogenetic ana...
gene expression...
mutation analys...
diagnostic labo...
immunologic tec...
allogeneic hema...
nonmyeloablativ...
- National Cancer Institute (NCI) View Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00651261 Leukemia
cytarabine
daunorubicin
midostaurin
placebo
dexamethasone a...
18 Years - 59 Years Alliance for Clinical Trials in Oncology View Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia NCT01385150 Leukemia
mutation analys...
protein analysi...
laboratory biom...
liquid chromato...
mass spectromet...
17 Years - 60 Years Eastern Cooperative Oncology Group View Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00027872 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Cellular Diagno...
Untreated Adult...
tipifarnib
laboratory biom...
65 Years - National Cancer Institute (NCI) View Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia NCT00352365 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
lenalidomide
60 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia NCT00006363 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 Years National Cancer Institute (NCI) View Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia NCT00217646 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult Erythrole...
Adult Pure Eryt...
Alkylating Agen...
Blastic Phase
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Secondary Myelo...
Sorafenib Tosyl...
18 Years - National Cancer Institute (NCI) View Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R NCT00534469 Leukemia
aldesleukin
filgrastim
busulfan
cytarabine
etoposide
idarubicin
autologous hema...
bone marrow tra...
peripheral bloo...
total-body irra...
16 Years - 60 Years City of Hope Medical Center View Cilengitide in Treating Patients With Acute Myeloid Leukemia NCT00089388 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
cilengitide
50 Years - National Cancer Institute (NCI) View Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy NCT01235572 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Previously Trea...
Recurrent Adult...
standard follow...
medical chart r...
quality-of-life...
18 Years - 75 Years Fred Hutchinson Cancer Center View Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy NCT02071901 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
eltrombopag ola...
60 Years - Case Comprehensive Cancer Center View Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia NCT00898456 Leukemia
gene expression...
molecular genet...
polymorphism an...
protein express...
diagnostic labo...
15 Years - Alliance for Clinical Trials in Oncology View Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase NCT00383474 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase
Recurrent Adult...
Recurrent Adult...
Recurrent Disea...
Untreated Adult...
Untreated Adult...
Bortezomib
Laboratory Biom...
Tipifarnib
18 Years - National Cancer Institute (NCI) View Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia NCT00131989 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
Recurrent Adult...
sorafenib tosyl...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML NCT00085709 Leukemia
gemtuzumab ozog...
observation
Cytosine arabin...
Daunomycin
18 Years - 60 Years SWOG Cancer Research Network View Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy NCT00509093 Leukemia
imatinib mesyla...
gene expression...
mutation analys...
polymerase chai...
flow cytometry
biopsy
18 Years - Case Comprehensive Cancer Center View Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00651261 Leukemia
cytarabine
daunorubicin
midostaurin
placebo
dexamethasone a...
18 Years - 59 Years Alliance for Clinical Trials in Oncology View S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia NCT01575535 Leukemia
gene expression...
flow cytometry
fluorescence ac...
laboratory biom...
medical chart r...
18 Years - SWOG Cancer Research Network View Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00407966 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
alvocidib
cytarabine
mitoxantrone hy...
18 Years - National Cancer Institute (NCI) View Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia NCT00096122 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Refractory Anem...
Refractory Anem...
Secondary Acute...
Secondary Myelo...
Untreated Adult...
cytarabine
idarubicin
tipifarnib
15 Years - 70 Years National Cancer Institute (NCI) View Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia NCT00096122 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Myelo...
Chronic Myelomo...
de Novo Myelody...
Refractory Anem...
Refractory Anem...
Secondary Acute...
Secondary Myelo...
Untreated Adult...
cytarabine
idarubicin
tipifarnib
15 Years - 70 Years National Cancer Institute (NCI) View Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT01550185 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
eltrombopag ola...
standard follow...
18 Years - Roswell Park Cancer Institute View Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT00775593 Leukemia
clofarabine
temsirolimus
60 Years - Gruppo Italiano Malattie EMatologiche dell'Adulto View Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00027872 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Cellular Diagno...
Untreated Adult...
tipifarnib
laboratory biom...
65 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00372593 Leukemia
asparaginase
cytarabine
daunorubicin hy...
etoposide
gemtuzumab ozog...
mitoxantrone hy...
- 29 Years Children's Oncology Group View S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy NCT01360125 Leukemia
proteomic profi...
flow cytometry
laboratory biom...
18 Years - 60 Years SWOG Cancer Research Network View Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia NCT00112554 Leukemia
cytarabine
laromustine
placebo
18 Years - National Cancer Institute (NCI) View Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy NCT02071901 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
eltrombopag ola...
60 Years - Case Comprehensive Cancer Center View Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy NCT02071901 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
eltrombopag ola...
60 Years - Case Comprehensive Cancer Center View Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01154439 Leukemia
cytarabine
etoposide
everolimus
idarubicin
mitoxantrone hy...
61 Years - 75 Years Gruppo Italiano Malattie EMatologiche dell'Adulto View Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia NCT01385150 Leukemia
mutation analys...
protein analysi...
laboratory biom...
liquid chromato...
mass spectromet...
17 Years - 60 Years Eastern Cooperative Oncology Group View Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00027872 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Cellular Diagno...
Untreated Adult...
tipifarnib
laboratory biom...
65 Years - National Cancer Institute (NCI) View Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment NCT01421862 Leukemia
DNA methylation...
RNA analysis
gene expression...
microarray anal...
mutation analys...
nucleic acid se...
laboratory biom...
18 Years - 65 Years National Cancer Institute (NCI) View S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy NCT01360125 Leukemia
proteomic profi...
flow cytometry
laboratory biom...
18 Years - 60 Years SWOG Cancer Research Network View Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT01550185 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
eltrombopag ola...
standard follow...
18 Years - Roswell Park Cancer Institute View Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia NCT00003758 Leukemia
cytarabine
idarubicin
allogeneic bone...
autologous bone...
peripheral bloo...
15 Years - 60 Years National Cancer Institute (NCI) View Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia NCT00006363 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 Years National Cancer Institute (NCI) View Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia NCT00217646 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult Erythrole...
Adult Pure Eryt...
Alkylating Agen...
Blastic Phase
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Secondary Myelo...
Sorafenib Tosyl...
18 Years - National Cancer Institute (NCI) View Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia NCT00217646 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Adult Erythrole...
Adult Pure Eryt...
Alkylating Agen...
Blastic Phase
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Secondary Acute...
Secondary Myelo...
Sorafenib Tosyl...
18 Years - National Cancer Institute (NCI) View Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia NCT00112554 Leukemia
cytarabine
laromustine
placebo
18 Years - National Cancer Institute (NCI) View Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia NCT00131989 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
Recurrent Adult...
sorafenib tosyl...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes NCT00098423 Accelerated Pha...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Chronic Myelomo...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Relapsing Chron...
Secondary Acute...
Secondary Myelo...
tanespimycin
cytarabine
18 Years - National Cancer Institute (NCI) View Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia NCT00101153 Leukemia
cytarabine
daunorubicin hy...
tipifarnib
56 Years - University Health Network, Toronto View XK469R in Treating Patients With Refractory Hematologic Cancer NCT00095797 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Chronic Myelomo...
de Novo Myelody...
Previously Trea...
Recurrent Adult...
Recurrent Adult...
Refractory Anem...
Refractory Anem...
Refractory Chro...
Relapsing Chron...
Secondary Myelo...
Stage III Chron...
Stage IV Chroni...
Untreated Adult...
R(+)XK469
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00091234 Leukemia
gemtuzumab ozog...
61 Years - European Organisation for Research and Treatment of Cancer - EORTC View Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia NCT00258271 Leukemia
filgrastim
cladribine
cytarabine
imatinib mesyla...
18 Years - University of Rochester View S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy NCT01360125 Leukemia
proteomic profi...
flow cytometry
laboratory biom...
18 Years - 60 Years SWOG Cancer Research Network View A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia NCT01656031 Leukemia
clofarabine
cytarabine
18 Years - 120 Years Wake Forest University Health Sciences View Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia NCT00898092 Leukemia
microarray anal...
molecular genet...
mutation analys...
polymerase chai...
reverse transcr...
diagnostic labo...
15 Years - 59 Years Alliance for Clinical Trials in Oncology View Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia NCT01159301 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Recurrent Adult...
Unspecified Adu...
entinostat
sorafenib tosyl...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia NCT00844441 Leukemia
Myelodysplastic...
medical chart r...
questionnaire a...
quality-of-life...
18 Years - 60 Years Fred Hutchinson Cancer Center View S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia NCT00023777 Leukemia
filgrastim
sargramostim
cytarabine
daunorubicin hy...
56 Years - SWOG Cancer Research Network View Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia NCT00258271 Leukemia
filgrastim
cladribine
cytarabine
imatinib mesyla...
18 Years - University of Rochester View Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01154439 Leukemia
cytarabine
etoposide
everolimus
idarubicin
mitoxantrone hy...
61 Years - 75 Years Gruppo Italiano Malattie EMatologiche dell'Adulto View Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00091234 Leukemia
gemtuzumab ozog...
61 Years - European Organisation for Research and Treatment of Cancer - EORTC View